S'abonner

Cesarean delivery is associated with lower neonatal mortality among breech pregnancies: a systematic review and meta-analysis of preterm deliveries ≤32 weeks of gestation - 20/11/24

Doi : 10.1016/j.ajog.2024.06.015 
Vivien Unger, MD a, b, Ákos Gasparics, MD, PhD a, c, d, Zsuzsanna Nagy, MD a, c, d, Márk Hernádfői, MD a, e, Rita Nagy, MD, PhD a, f, Anna Walter, MSc g, Nelli Farkas, MSc g, Miklós Szabó, MD, DSc a, d, Péter Hegyi, MD, DSc a, g, h, Miklós Garami, MD, MSc, PhD a, i, Péter Varga, MD, PhD a, c, d,
a Centre for Translational Medicine, Semmelweis University, Budapest, Hungary 
b Pediatric Center, Csolnoky Ferenc Hospital, Veszprém, Hungary 
c Department of Obstetrics and Gynecology, Semmelweis University, Budapest, Hungary 
d Division of Neonatology, Pediatric Center, Semmelweis University, Budapest, Hungary 
e Bethesda Children's Hospital, Budapest, Hungary 
f Heim Pál National Pediatric Institute, Budapest, Hungary 
g Institute for Translational Medicine, University of Pécs, Pécs, Hungary 
h Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary 
i Pediatric Center, Semmelweis University, Budapest, Hungary 

Corresponding author: Péter Varga MD, PhD.

Abstract

Objective

To investigate the association between actual and planned modes of delivery, neonatal mortality, and short-term outcomes among preterm pregnancies ≤32 weeks of gestation.

Data Sources

A systematic literature search was conducted in 3 main databases (PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials from inception to November 16, 2022. The protocol was registered in advance in the International Prospective Register of Systematic Reviews (CRD42022377870).

Study Eligibility Criteria

Eligible studies examined pregnancies ≤32nd gestational week. All infants received active care, and the outcomes were reported separately by different modes of delivery. Singleton and twin pregnancies at vertex and breech presentations were included. Studies that included pregnancies complicated with preeclampsia and abruptio placentae were excluded. Primary outcomes were neonatal mortality and intraventricular hemorrhage.

Study Appraisal and Synthesis Methods

Articles were selected by title, abstract, and full text, and disagreements were resolved by consensus. Random effects model-based odds ratios with corresponding 95% confidence intervals were calculated for dichotomous outcomes. Risk Of Bias In Non-randomized Studies - of Interventions-I was used to assess the risk of bias.

Results

A total of 19 observational studies were included involving a total of 16,042 preterm infants in this systematic review and meta-analysis. Actual cesarean delivery improves survival (odds ratio, 0.62; 95% confidence interval, 0.42–0.9) and decreases the incidence of intraventricular hemorrhage (odds ratio, 0.70; confidence interval, 0.57–0.85) compared to vaginal delivery. Planned cesarean delivery does not improve the survival of very and extremely preterm infants compared to vaginal delivery (odds ratio, 0.87; 95% confidence interval, 0.53–1.44). Subset analysis found significantly lower odds of death for singleton breech preterm deliveries born by both planned (odds ratio, 0.56; 95% confidence interval, 0.32–0.98) and actual (odds ratio, 0.34; 95% confidence interval, 0.13–0.88) cesarean delivery.

Conclusion

Cesarean delivery should be the mode of delivery for preterm ≤32 weeks of gestation breech births due to the higher mortality in preterm infants born via vaginal delivery.

Le texte complet de cet article est disponible en PDF.

Video


(13.42 Mo)

Le texte complet de cet article est disponible en PDF.

Key words : breech, cephalic, cesarean delivery, intraventricular hemorrhage, mode of delivery, neonatal mortality, planned cesarean section, survival, twin, vaginal delivery, vertex, very preterm birth


Plan


 The authors report no conflict of interest.
 Ethics statement: Ethical approval was not required for this systematic review and meta-analysis, given that all data had already been published in peer-reviewed journals. Our study did not involve any patients in the design, implementation, or data interpretation process.
 PROSPERO registration: 16/11/2022 (CRD42022377870).


© 2024  The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 231 - N° 6

P. 589 - décembre 2024 Retour au numéro
Article précédent Article précédent
  • Prenatal cannabis exposure and the risk for neuropsychiatric anomalies in the offspring: a systematic review and meta-analysis
  • Hely Bassalov, Noa Yakirevich-Amir, Inbal Reuveni, Catherine Monk, Sharon Florentin, Omer Bonne, Ilan Matok
| Article suivant Article suivant
  • Fertility-preserving treatment for stage IA endometrial cancer: a systematic review and meta-analysis
  • Yukio Suzuki, Jennifer S. Ferris, Ling Chen, Shayan Dioun, John Usseglio, Koji Matsuo, Xiao Xu, Dawn L. Hershman, Jason D. Wright

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.